News
UNC Hospitals Earns National Recognition for Nursing Excellence
UNC Hospitals is one of 378 facilities in the world, and among only 6 percent of all U.S. hospitals, that have earned Magnet designation.
UNC Named LIVESTRONG® Community Impact Project Award Recipient
Organization will receive The Artist in Residence Program to help people affected by cancer
UNC Startup Receives Federal Grant to Kick-Start Cancer Research Commercialization
G-Zero Therapeutics funded under Qualifying Therapeutic Discovery Project
UNC Team Discovers Promising Target for New Pancreatic Cancer Treatments
Cell signaling protein may hold key to blocking long-studied genetic mutation
Drug That Inhibits Vascular Development Does Not Help Colon Cancer Survival
In a study published this month in the Journal of Clinical Oncology, the results of a clinical trial of the drug bevacizumab to treat colon cancer in combination with the standard therapy found that the drug did not significantly increase disease-free survival in patients with stage II and stage III colon cancer.
